HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALPHAMAB-B

8.370

-0.185-2.16%

Volume:319.00K

Turnover:2.70M

Market Cap:8.11B

PE:-59.98

High:8.530

Open:8.425

Low:8.360

Close:8.555

52wk High:15.750

52wk Low:6.230

Shares:969.00M

HK Float Shares:969.00M

Volume Ratio:0.42

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.140

ROE:-6.43%

ROA:-4.42%

PB:4.08

PE(LYR):-59.98

PS:12.32

Loading ...

Overview Company News Filings

Alphamab Oncology Licenses Cancer Drug Candidate to Pathos AI for Up to $2.09 Billion

MT Newswires Live

Alphamab Oncology (ALPHAMAB-B) Reports Stable Share Capital and Option Movements for July 2026

Bulletin Express

CSPC Pharma Unit, Alphamab Oncology's Breast Cancer Drug Application Granted Priority Review in China

MT Newswires Live

ALPHAMAB-B's Novel Drug Application for Anniutuo (KN026) in HER2-Positive Breast Cancer Neoadjuvant Therapy Accepted by Chinese Regulator

Alphamab Oncology receives NMPA priority review for Anbenitamab NDA in neoadjuvant HER2+ breast-cancer therapy

Bulletin Express

Alphamab Oncology Says NMPA Accepts NDA for Anbenitamab (kn026)

Alphamab Oncology - Nmpa Accepts Nda for Anbenitamab (Kn026) as Neoadjuvant Her2+ Breast Cancer Treatment

THOMSON REUTERS

HK-Listed Alphamab Hits 2-Month High on Breast Cancer Drug Licensing Deal

ALPHAMAB-B Surges Over 12% in Morning Trade Following $2.1 Billion TROP2/HER3 Dual Antibody ADC Export Licensing Deal

Alphamab Oncology - Jiangsu Alphamab to Receive $125 Mln Upfront, up to $2.09 Bln Total from Pathos AI

THOMSON REUTERS

Alphamab Oncology - Unit Granted Pathos AI Exclusive License to Commercialize Jskn016 in Territories Outside Chinese Mainland, HK, Macau, Taiwan

THOMSON REUTERS

Alphamab Oncology Licenses Jskn016 Ex-China Rights to Pathos AI for up to USD 2.09 Billion

Pathos AI Enters Global Licensing Agreement with Alphamab Oncology on Jskn016, a First-in-Class Trop2/Her3 Bispecific ADC

THOMSON REUTERS

Alphamab Oncology Announces Approval from CDE for Jskn033 to Initiate a Phase III Clinical Study

ALPHAMAB-B wins CDE green light to start Phase III trial of subcutaneous bispecific ADC/PD-L1 combo JSKN033 for hard-to-treat cervical cancer

Bulletin Express

Alphamab Oncology - Approval from Cde for Jskn033 to Initiate a Phase Iii Clinical Study for Treatment of Cervical Cancer

THOMSON REUTERS

Alphamab Oncology Says China CDE Clears Jskn033 Phase 3 Trial in Recurrent or Metastatic Cervical Cancer

Alphamab-B Shares Surge 10% on Breakthrough Therapy Designation for Breast Cancer Treatment

Alphamab Oncology Says China Regulator Grants Breakthrough Tag for Anbenitamab in First-line HER2+ Advanced Breast Cancer

Alphamab Oncology - Anbenitamab (kn026) Granted Breakthrough Therapy Designation by Nmpa for Her2+ Breast Cancer

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/09966/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09966","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09966\",,,,,undefined,":{"symbol":"09966","market":"HK","secType":"STK","nameCN":"ALPHAMAB-B","latestPrice":8.37,"timestamp":1786516485701,"preClose":8.555,"halted":0,"volume":319000,"delay":0,"changeRate":-0.02162478082992408,"floatShares":969000000,"shares":969000000,"eps":-0.1395360881369764,"marketStatus":"Trading","change":-0.185,"latestTime":"08-12 14:35:23","open":8.425,"high":8.53,"low":8.36,"amount":2700415,"amplitude":0.019871,"askPrice":8.39,"askSize":3000,"bidPrice":8.37,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-0.1395360881369764,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1786522200000},"marketStatusCode":2,"adr":0,"listingDate":1576080000000,"exchange":"SEHK","adjPreClose":8.555,"openAndCloseTimeList":[[1786498200000,1786507200000],[1786510800000,1786521600000]],"volumeRatio":0.418879,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09966\",,,,,undefined,":{"symbol":"09966","floatShares":969000000,"roa":"-4.42%","roe":"-6.43%","lyrEps":-0.139536,"volumeRatio":0.418879,"shares":969000000,"dividePrice":0,"high":8.53,"amplitude":0.019871,"preClose":8.555,"low":8.36,"week52Low":6.23,"pbRate":"4.08","psRate":"12.32","week52High":15.75,"institutionHeld":0,"latestPrice":8.37,"eps":-0.1395360881369764,"divideRate":0,"volume":319000,"delay":0,"ttmEps":-0.1395360881369764,"open":8.425,"prevYearClose":9.8,"prevWeekClose":8.02,"prevMonthClose":7.47,"prevQuarterClose":6.95,"fiveDayClose":7.895,"twentyDayClose":7.92,"sixtyDayClose":8.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09966\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2026-03-25","symbol":"09966","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774368000000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-28","symbol":"09966","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null},{"date":"2025-03-25","symbol":"09966","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"Post-Mkt","dateTimestamp":1742832000000,"actualEps":null},{"date":"2024-08-15","symbol":"09966","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723685400000,"name":null,"time":"Post-Mkt","dateTimestamp":1723651200000,"actualEps":null},{"date":"2024-03-28","symbol":"09966","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711589400000,"name":null,"time":"","dateTimestamp":1711555200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09966\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09966\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.8,"buy":0.2,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.8,"analysts":5,"updateTime":1769184000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09966\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09966","date":"2026-08-10","current":-61.294721,"percent":0.030919,"low":-88.862928,"twenty":-32.226362,"median":-17.873419,"eighty":28.196225,"high":58.684884,"avg":-12.435256,"sd":30.089997,"marketCap":8222621857},"quantilePoints":[{"date":"2021-08-13","current":-38.508707,"twenty":-39.722433,"median":-22.932411,"eighty":-12.6217,"marketCap":19792944513},{"date":"2021-08-20","current":-31.697919,"twenty":-39.717213,"median":-24.391692,"eighty":-12.731852,"marketCap":16246123723},{"date":"2021-08-27","current":-23.511847,"twenty":-39.47908,"median":-24.785868,"eighty":-12.75148,"marketCap":16751475498},{"date":"2021-09-03","current":-27.638176,"twenty":-39.439714,"median":-25.947128,"eighty":-12.792826,"marketCap":19699360851},{"date":"2021-09-10","current":-30.382936,"twenty":-39.401539,"median":-26.640453,"eighty":-12.799389,"marketCap":21711409584},{"date":"2021-09-17","current":-26.992304,"twenty":-39.104645,"median":-26.783416,"eighty":-12.828856,"marketCap":19231442541},{"date":"2021-09-24","current":-24.472208,"twenty":-38.971499,"median":-26.752109,"eighty":-12.847091,"marketCap":17443994596},{"date":"2021-09-30","current":-23.082076,"twenty":-38.810991,"median":-26.645817,"eighty":-12.874922,"marketCap":16508157976},{"date":"2021-10-08","current":-22.481188,"twenty":-38.703179,"median":-26.190542,"eighty":-12.957107,"marketCap":16077673131},{"date":"2021-10-15","current":-22.073477,"twenty":-38.672506,"median":-25.693365,"eighty":-13.062755,"marketCap":15796922145},{"date":"2021-10-22","current":-23.032708,"twenty":-38.647454,"median":-24.836506,"eighty":-13.216108,"marketCap":16601741638},{"date":"2021-10-29","current":-20.929201,"twenty":-38.590118,"median":-24.43195,"eighty":-13.328983,"marketCap":15048252849},{"date":"2021-11-05","current":-19.049585,"twenty":-38.456765,"median":-23.785332,"eighty":-13.397234,"marketCap":13719364849},{"date":"2021-11-12","current":-21.352494,"twenty":-38.349074,"median":-23.685099,"eighty":-13.500511,"marketCap":15441304230},{"date":"2021-11-19","current":-23.559904,"twenty":-38.09836,"median":-23.566387,"eighty":-13.594759,"marketCap":17013509751},{"date":"2021-11-26","current":-24.796984,"twenty":-37.741225,"median":-23.751485,"eighty":-13.636547,"marketCap":17912582806},{"date":"2021-12-03","current":-23.432191,"twenty":-37.532346,"median":-23.768698,"eighty":-13.650686,"marketCap":16957993754},{"date":"2021-12-10","current":-21.429631,"twenty":-37.255577,"median":-23.601157,"eighty":-13.734345,"marketCap":15535211631},{"date":"2021-12-17","current":-17.822954,"twenty":-37.096113,"median":-23.511847,"eighty":-13.85618,"marketCap":12911653575},{"date":"2021-12-24","current":-17.909322,"twenty":-36.853053,"median":-23.44502,"eighty":-13.888948,"marketCap":12986612377},{"date":"2021-12-31","current":-17.535218,"twenty":-36.556554,"median":-23.429856,"eighty":-13.94459,"marketCap":12742996272},{"date":"2022-01-07","current":-15.893614,"twenty":-17.170858,"median":-16.499144,"eighty":-15.831692,"marketCap":11506176045},{"date":"2022-01-14","current":-16.943897,"twenty":-17.170858,"median":-16.521118,"eighty":-16.202208,"marketCap":12293243462},{"date":"2022-01-21","current":-16.029012,"twenty":-17.088796,"median":-16.543092,"eighty":-16.256367,"marketCap":11656093648},{"date":"2022-01-28","current":-12.285046,"twenty":-17.06511,"median":-16.479323,"eighty":-15.418562,"marketCap":8910727540},{"date":"2022-02-04","current":-12.601255,"twenty":-17.064989,"median":-16.436633,"eighty":-13.889332,"marketCap":9135603945},{"date":"2022-02-11","current":-12.640346,"twenty":-17.064,"median":-16.029012,"eighty":-13.029958,"marketCap":9182453196},{"date":"2022-02-18","current":-12.116498,"twenty":-16.945463,"median":-15.716538,"eighty":-12.878125,"marketCap":8845138588},{"date":"2022-02-25","current":-12.112309,"twenty":-16.943897,"median":-13.889332,"eighty":-12.601255,"marketCap":8863878289},{"date":"2022-03-04","current":-10.48082,"twenty":-16.543092,"median":-13.037325,"eighty":-12.112309,"marketCap":7672881063},{"date":"2022-03-11","current":-9.328946,"twenty":-16.517271,"median":-13.027408,"eighty":-11.794703,"marketCap":6819296495},{"date":"2022-03-18","current":-10.345437,"twenty":-16.499144,"median":-12.881139,"eighty":-11.440921,"marketCap":7532180310},{"date":"2022-03-25","current":-10.293471,"twenty":-16.459503,"median":-12.785641,"eighty":-10.48082,"marketCap":7494660109},{"date":"2022-04-01","current":-14.297066,"twenty":-16.413764,"median":-12.859655,"eighty":-10.48082,"marketCap":7260158854},{"date":"2022-04-08","current":-15.491011,"twenty":-16.409102,"median":-12.884734,"eighty":-10.570438,"marketCap":7869862117},{"date":"2022-04-14","current":-13.574781,"twenty":-16.284169,"median":-13.028683,"eighty":-10.933821,"marketCap":6884956846},{"date":"2022-04-22","current":-12.815632,"twenty":-16.132599,"median":-12.892105,"eighty":-11.273053,"marketCap":6378434136},{"date":"2022-04-29","current":-15.496239,"twenty":-15.992174,"median":-12.898894,"eighty":-11.449013,"marketCap":7588460611},{"date":"2022-05-06","current":-14.409179,"twenty":-15.928257,"median":-13.029958,"eighty":-11.46436,"marketCap":6997517449},{"date":"2022-05-13","current":-13.039318,"twenty":-15.893614,"median":-13.039318,"eighty":-11.477201,"marketCap":6218973282},{"date":"2022-05-20","current":-14.565659,"twenty":-15.738809,"median":-13.068955,"eighty":-11.584492,"marketCap":7044417700},{"date":"2022-05-27","current":-12.908885,"twenty":-15.694268,"median":-13.170134,"eighty":-11.742961,"marketCap":6237733383},{"date":"2022-06-02","current":-15.137652,"twenty":-15.684864,"median":-13.379031,"eighty":-11.784355,"marketCap":7353959356},{"date":"2022-06-10","current":-16.505757,"twenty":-15.940348,"median":-13.514449,"eighty":-11.948913,"marketCap":7964685112},{"date":"2022-06-17","current":-15.374218,"twenty":-15.902275,"median":-13.574781,"eighty":-12.01146,"marketCap":7410538389},{"date":"2022-06-24","current":-18.243922,"twenty":-16.040638,"median":-13.677347,"eighty":-12.020595,"marketCap":8828778309},{"date":"2022-06-30","current":-15.728498,"twenty":-16.132948,"median":-13.734552,"eighty":-12.075937,"marketCap":7598384736},{"date":"2022-07-08","current":-15.401573,"twenty":-16.213925,"median":-14.214649,"eighty":-12.114822,"marketCap":7448107658},{"date":"2022-07-15","current":-13.957754,"twenty":-16.132948,"median":-14.253329,"eighty":-12.158169,"marketCap":6687329953},{"date":"2022-07-22","current":-13.556788,"twenty":-16.052264,"median":-13.957754,"eighty":-12.241614,"marketCap":6499483606},{"date":"2022-07-29","current":-12.816298,"twenty":-15.984046,"median":-13.734552,"eighty":-12.282517,"marketCap":6151967864},{"date":"2022-08-05","current":-12.849025,"twenty":-15.951796,"median":-13.67889,"eighty":-12.241614,"marketCap":6151967864},{"date":"2022-08-12","current":-12.126293,"twenty":-15.942263,"median":-13.653572,"eighty":-12.13744,"marketCap":5813844439},{"date":"2022-08-19","current":-11.754194,"twenty":-15.910936,"median":-13.561425,"eighty":-12.101504,"marketCap":5579036505},{"date":"2022-08-26","current":-14.820088,"twenty":-15.819231,"median":-13.568103,"eighty":-12.114822,"marketCap":6978491791},{"date":"2022-09-02","current":-23.46609,"twenty":-15.942263,"median":-13.639619,"eighty":-12.119419,"marketCap":7805015717},{"date":"2022-09-09","current":-22.421914,"twenty":-16.132948,"median":-13.677347,"eighty":-12.124322,"marketCap":7429323023},{"date":"2022-09-16","current":-20.513842,"twenty":-16.411433,"median":-13.695704,"eighty":-12.133724,"marketCap":6734291539},{"date":"2022-09-23","current":-18.727552,"twenty":-16.482452,"median":-13.764182,"eighty":-12.145399,"marketCap":6029867738},{"date":"2022-09-30","current":-17.760163,"twenty":-16.512665,"median":-14.086201,"eighty":-12.162095,"marketCap":5729313583},{"date":"2022-10-07","current":-17.557368,"twenty":-16.549697,"median":-14.253329,"eighty":-12.200956,"marketCap":5663567362},{"date":"2022-10-14","current":-18.422453,"twenty":-17.040293,"median":-14.409179,"eighty":-12.26158,"marketCap":5879590661},{"date":"2022-10-21","current":-18.312429,"twenty":-17.110066,"median":-14.521212,"eighty":-12.266929,"marketCap":5804452122},{"date":"2022-10-28","current":-16.711302,"twenty":-17.217664,"median":-14.625046,"eighty":-12.279988,"marketCap":5287874668},{"date":"2022-11-04","current":-22.018013,"twenty":-17.339043,"median":-14.652332,"eighty":-12.287313,"marketCap":7034845695},{"date":"2022-11-11","current":-21.415614,"twenty":-17.446229,"median":-14.695745,"eighty":-12.339559,"marketCap":6903353252},{"date":"2022-11-18","current":-27.349007,"twenty":-17.693119,"median":-14.898563,"eighty":-12.519492,"marketCap":8785789555},{"date":"2022-11-25","current":-23.765769,"twenty":-17.972543,"median":-14.987518,"eighty":-12.558957,"marketCap":7574114079},{"date":"2022-12-02","current":-26.174182,"twenty":-18.335139,"median":-15.067608,"eighty":-12.605734,"marketCap":8485638974},{"date":"2022-12-09","current":-28.776484,"twenty":-18.700907,"median":-15.204594,"eighty":-12.62699,"marketCap":9415958197},{"date":"2022-12-16","current":-29.361916,"twenty":-19.228432,"median":-15.373796,"eighty":-12.660178,"marketCap":9585107147},{"date":"2022-12-23","current":-29.065003,"twenty":-19.518662,"median":-15.491011,"eighty":-12.748732,"marketCap":9491135508},{"date":"2022-12-30","current":-30.706351,"twenty":-20.691058,"median":-15.537108,"eighty":-12.776414,"marketCap":10148936979},{"date":"2023-01-06","current":-34.446644,"twenty":-21.092014,"median":-15.642909,"eighty":-12.803636,"marketCap":11502128576},{"date":"2023-01-13","current":-37.5558,"twenty":-22.093247,"median":-15.694268,"eighty":-12.816032,"marketCap":12780142863},{"date":"2023-01-20","current":-34.984086,"twenty":-22.45467,"median":-15.754226,"eighty":-12.83123,"marketCap":11802837820},{"date":"2023-01-27","current":-36.369324,"twenty":-23.121815,"median":-15.831629,"eighty":-12.841184,"marketCap":12272696014},{"date":"2023-02-03","current":-44.714918,"twenty":-23.888047,"median":-15.950281,"eighty":-12.849025,"marketCap":15167022486},{"date":"2023-02-10","current":-41.260502,"twenty":-24.093097,"median":-16.058077,"eighty":-12.878125,"marketCap":13911210300},{"date":"2023-02-17","current":-40.325712,"twenty":-25.009317,"median":-16.232327,"eighty":-12.884153,"marketCap":13467440762},{"date":"2023-02-24","current":-41.468197,"twenty":-25.82041,"median":-16.421267,"eighty":-12.885315,"marketCap":13679678367},{"date":"2023-03-03","current":-43.817626,"twenty":-27.026978,"median":-16.467172,"eighty":-12.898894,"marketCap":14547923115},{"date":"2023-03-10","current":-38.640155,"twenty":-41.544229,"median":-39.606335,"eighty":-38.921385,"marketCap":12734256308},{"date":"2023-03-17","current":-45.981837,"twenty":-36.747123,"median":-18.243922,"eighty":-13.756749,"marketCap":15300401897},{"date":"2023-03-24","current":-41.160417,"twenty":-37.327637,"median":-18.28036,"eighty":-13.766939,"marketCap":13853327317},{"date":"2023-03-31","current":-38.068943,"twenty":-38.013012,"median":-18.315502,"eighty":-13.778887,"marketCap":12714961980},{"date":"2023-04-06","current":-43.295967,"twenty":-38.403453,"median":-18.336928,"eighty":-13.781651,"marketCap":14451451477},{"date":"2023-04-14","current":-43.747506,"twenty":-38.561286,"median":-18.405859,"eighty":-13.793666,"marketCap":16284412612},{"date":"2023-04-21","current":-39.932363,"twenty":-38.703179,"median":-18.48348,"eighty":-13.816299,"marketCap":14856632359},{"date":"2023-04-28","current":-39.970681,"twenty":-39.225939,"median":-18.621321,"eighty":-13.840508,"marketCap":14760160721},{"date":"2023-05-05","current":-40.166061,"twenty":-39.290038,"median":-18.683461,"eighty":-13.852302,"marketCap":14856632359},{"date":"2023-05-12","current":-36.925364,"twenty":-39.290038,"median":-18.774651,"eighty":-13.85982,"marketCap":13563912401},{"date":"2023-05-19","current":-24.719387,"twenty":-39.117221,"median":-18.879869,"eighty":-13.865832,"marketCap":8952568071},{"date":"2023-05-25","current":-23.29845,"twenty":-39.108027,"median":-18.921163,"eighty":-13.869727,"marketCap":8403228460},{"date":"2023-06-02","current":-21.901518,"twenty":-39.071359,"median":-18.943448,"eighty":-13.885174,"marketCap":7872599797},{"date":"2023-06-09","current":-20.454824,"twenty":-38.924331,"median":-19.035121,"eighty":-13.891345,"marketCap":7341971135},{"date":"2023-06-16","current":-22.146741,"twenty":-38.853024,"median":-19.126864,"eighty":-13.899678,"marketCap":7911190973},{"date":"2023-06-23","current":-18.955124,"twenty":-38.789903,"median":-19.149261,"eighty":-13.900804,"marketCap":6734160121},{"date":"2023-06-30","current":-20.498364,"twenty":-38.749431,"median":-19.291559,"eighty":-13.923916,"marketCap":7216549814},{"date":"2023-07-07","current":-25.123882,"twenty":-38.726176,"median":-19.347276,"eighty":-13.932185,"marketCap":8827731391},{"date":"2023-07-14","current":-25.317769,"twenty":-38.687847,"median":-19.399951,"eighty":-13.94759,"marketCap":9020687268},{"date":"2023-07-21","current":-25.381576,"twenty":-38.649495,"median":-19.466605,"eighty":-13.957754,"marketCap":9001391680},{"date":"2023-07-28","current":-27.451279,"twenty":-38.644392,"median":-19.47828,"eighty":-13.964689,"marketCap":9724976220},{"date":"2023-08-04","current":-23.653749,"twenty":-38.640155,"median":-19.530791,"eighty":-13.983912,"marketCap":8393580666},{"date":"2023-08-11","current":-21.299887,"twenty":-38.508707,"median":-19.571912,"eighty":-14.027277,"marketCap":7515631424},{"date":"2023-08-18","current":-19.250306,"twenty":-38.506952,"median":-19.585154,"eighty":-14.027284,"marketCap":6743807915},{"date":"2023-08-25","current":-32.203663,"twenty":-38.501855,"median":-19.663677,"eighty":-14.080878,"marketCap":7563870394},{"date":"2023-09-01","current":-35.302101,"twenty":-38.378852,"median":-19.736206,"eighty":-14.101892,"marketCap":8326046109},{"date":"2023-09-08","current":-34.605021,"twenty":-38.304408,"median":-19.857796,"eighty":-14.114833,"marketCap":8065555675},{"date":"2023-09-15","current":-37.542629,"twenty":-38.132108,"median":-19.912369,"eighty":-14.137969,"marketCap":8818083597},{"date":"2023-09-22","current":-38.573862,"twenty":-38.378852,"median":-20.085413,"eighty":-14.152594,"marketCap":9020687268},{"date":"2023-09-29","current":-35.418957,"twenty":-38.378852,"median":-20.217001,"eighty":-14.161696,"marketCap":8297102728},{"date":"2023-10-06","current":-35.229903,"twenty":-38.322726,"median":-20.283173,"eighty":-14.166678,"marketCap":8248863758},{"date":"2023-10-13","current":-40.523415,"twenty":-38.502874,"median":-20.44317,"eighty":-14.173688,"marketCap":9474133580},{"date":"2023-10-20","current":-39.594032,"twenty":-38.521738,"median":-20.486571,"eighty":-14.206745,"marketCap":9242586527},{"date":"2023-10-27","current":-47.54977,"twenty":-38.64185,"median":-20.513842,"eighty":-14.216906,"marketCap":11094962950},{"date":"2023-11-03","current":-48.331086,"twenty":-38.735478,"median":-20.568945,"eighty":-14.224134,"marketCap":11307214415},{"date":"2023-11-10","current":-53.868252,"twenty":-39.004786,"median":-20.622682,"eighty":-14.233193,"marketCap":12600018794},{"date":"2023-11-17","current":-25.63055,"twenty":-39.106336,"median":-20.683961,"eighty":-14.258177,"marketCap":6049166756},{"date":"2023-11-24","current":-27.205215,"twenty":-39.004786,"median":-20.741333,"eighty":-14.276226,"marketCap":6473669686},{"date":"2023-12-01","current":-25.600638,"twenty":-38.896568,"median":-20.808578,"eighty":-14.289723,"marketCap":6117109736},{"date":"2023-12-08","current":-25.866704,"twenty":-38.821463,"median":-20.929201,"eighty":-14.323551,"marketCap":6155703488},{"date":"2023-12-15","current":-26.927511,"twenty":-38.76562,"median":-20.967194,"eighty":-14.351434,"marketCap":6445156630},{"date":"2023-12-22","current":-25.009304,"twenty":-38.735478,"median":-21.013037,"eighty":-14.35931,"marketCap":5982031603},{"date":"2023-12-29","current":-26.642107,"twenty":-38.71851,"median":-21.050342,"eighty":-14.361696,"marketCap":6406562878},{"date":"2024-01-05","current":-24.972539,"twenty":-38.687847,"median":-21.103846,"eighty":-14.368415,"marketCap":5962734727},{"date":"2024-01-12","current":-24.595768,"twenty":-38.649495,"median":-21.157012,"eighty":-14.402891,"marketCap":5875898784},{"date":"2024-01-19","current":-19.938246,"twenty":-38.644392,"median":-21.228449,"eighty":-14.409179,"marketCap":4756679968},{"date":"2024-01-26","current":-18.554521,"twenty":-38.640155,"median":-21.10942,"eighty":-14.411483,"marketCap":4409336197},{"date":"2024-02-02","current":-16.464276,"twenty":-38.588501,"median":-21.050342,"eighty":-14.423239,"marketCap":3907617418},{"date":"2024-02-09","current":-17.233111,"twenty":-38.573862,"median":-20.972717,"eighty":-14.434059,"marketCap":4110234617},{"date":"2024-02-16","current":-18.402278,"twenty":-38.534769,"median":-20.967194,"eighty":-14.439295,"marketCap":4390039321},{"date":"2024-02-23","current":-19.760229,"twenty":-38.507654,"median":-20.929201,"eighty":-14.453404,"marketCap":4689140902},{"date":"2024-03-01","current":-19.95108,"twenty":-38.503894,"median":-20.872963,"eighty":-14.464872,"marketCap":4737383092},{"date":"2024-03-08","current":-18.926824,"twenty":-38.428053,"median":-20.756308,"eighty":-14.480891,"marketCap":4496172140},{"date":"2024-03-15","current":-21.138772,"twenty":-38.336758,"median":-20.808578,"eighty":-14.489737,"marketCap":5017187796},{"date":"2024-03-22","current":-18.228539,"twenty":-38.306123,"median":-20.756308,"eighty":-14.50055,"marketCap":4322500255},{"date":"2024-03-28","current":-18.491125,"twenty":-38.279384,"median":-20.741333,"eighty":-14.518511,"marketCap":4370742445},{"date":"2024-04-05","current":-17.315482,"twenty":-38.241849,"median":-20.708906,"eighty":-14.534718,"marketCap":3946211170},{"date":"2024-04-12","current":-19.505885,"twenty":-38.177223,"median":-20.641249,"eighty":-14.539083,"marketCap":4447929950},{"date":"2024-04-19","current":-17.235745,"twenty":-38.132108,"median":-20.593675,"eighty":-14.549119,"marketCap":3926914294},{"date":"2024-04-26","current":-19.801056,"twenty":-38.068943,"median":-20.560672,"eighty":-14.563882,"marketCap":4505820578},{"date":"2024-05-03","current":-22.021106,"twenty":-38.043702,"median":-20.560672,"eighty":-14.565304,"marketCap":5007539358},{"date":"2024-05-10","current":-22.138266,"twenty":-38.000701,"median":-20.593675,"eighty":-14.571149,"marketCap":5046133110},{"date":"2024-05-17","current":-21.882428,"twenty":-37.938675,"median":-20.631965,"eighty":-14.596889,"marketCap":4980496851},{"date":"2024-05-24","current":-19.842196,"twenty":-37.865243,"median":-20.622682,"eighty":-14.620281,"marketCap":4505820578},{"date":"2024-05-31","current":-10.782036,"twenty":-37.809484,"median":-20.568945,"eighty":-14.569777,"marketCap":2450906469},{"date":"2024-06-07","current":-12.112976,"twenty":-37.717193,"median":-20.522014,"eighty":-14.537337,"marketCap":2750032849},{"date":"2024-06-14","current":-11.400893,"twenty":-37.653981,"median":-20.498364,"eighty":-14.489697,"marketCap":2585995802},{"date":"2024-06-21","current":-10.998512,"twenty":-37.601075,"median":-20.467365,"eighty":-14.43755,"marketCap":2489503422},{"date":"2024-06-28","current":-10.23542,"twenty":-37.550532,"median":-20.444852,"eighty":-14.405406,"marketCap":2315817136},{"date":"2024-07-05","current":-9.939046,"twenty":-37.533657,"median":-20.379051,"eighty":-14.358604,"marketCap":2248272470},{"date":"2024-07-12","current":-9.967061,"twenty":-37.482408,"median":-20.291848,"eighty":-14.273743,"marketCap":2257921708},{"date":"2024-07-19","current":-9.498347,"twenty":-37.402324,"median":-20.229766,"eighty":-14.215401,"marketCap":2151780089},{"date":"2024-07-26","current":-9.208575,"twenty":-37.327637,"median":-20.193614,"eighty":-14.154414,"marketCap":2093884661},{"date":"2024-08-02","current":-9.723471,"twenty":-37.32352,"median":-20.137385,"eighty":-14.085081,"marketCap":2209675518},{"date":"2024-08-09","current":-9.785633,"twenty":-37.276776,"median":-20.11618,"eighty":-13.968534,"marketCap":2238623232},{"date":"2024-08-16","current":-10.459398,"twenty":-37.131301,"median":-20.033441,"eighty":-13.92557,"marketCap":2450906469},{"date":"2024-08-23","current":-9.595269,"twenty":-37.054596,"median":-19.957659,"eighty":-13.885174,"marketCap":2257921708},{"date":"2024-08-30","current":-10.057543,"twenty":-37.014228,"median":-19.927086,"eighty":-13.851089,"marketCap":2382591163},{"date":"2024-09-06","current":-9.272587,"twenty":-36.98439,"median":-19.877354,"eighty":-13.778887,"marketCap":2197696119},{"date":"2024-09-13","current":-10.071667,"twenty":-36.894129,"median":-19.843829,"eighty":-13.713216,"marketCap":2380837463},{"date":"2024-09-20","current":-10.781754,"twenty":-36.769187,"median":-19.822249,"eighty":-13.694027,"marketCap":2563978806},{"date":"2024-09-27","current":-12.328923,"twenty":-36.726748,"median":-19.766991,"eighty":-13.667525,"marketCap":2949539529},{"date":"2024-10-04","current":-19.265835,"twenty":-36.672442,"median":-19.722789,"eighty":-13.668964,"marketCap":4588172601},{"date":"2024-10-10","current":-17.028579,"twenty":-36.626927,"median":-19.702627,"eighty":-13.673211,"marketCap":4029109553},{"date":"2024-10-18","current":-16.380704,"twenty":-36.583892,"median":-19.632926,"eighty":-13.677655,"marketCap":3855607228},{"date":"2024-10-25","current":-16.381742,"twenty":-36.520467,"median":-19.62099,"eighty":-13.687972,"marketCap":3855607228},{"date":"2024-11-01","current":-15.01467,"twenty":-36.416733,"median":-19.585154,"eighty":-13.696039,"marketCap":3536235131},{"date":"2024-11-08","current":-16.963396,"twenty":-36.363867,"median":-19.546761,"eighty":-13.701906,"marketCap":3977073562},{"date":"2024-11-15","current":-19.884819,"twenty":-36.278398,"median":-19.531887,"eighty":-13.707553,"marketCap":4612634955},{"date":"2024-11-22","current":-18.108329,"twenty":-36.210789,"median":-19.505972,"eighty":-13.721035,"marketCap":4198557078},{"date":"2024-11-29","current":-15.834641,"twenty":-36.188592,"median":-19.472152,"eighty":-13.744476,"marketCap":3668922584},{"date":"2024-12-06","current":-15.695605,"twenty":-36.08373,"median":-19.458841,"eighty":-13.760466,"marketCap":3628141712},{"date":"2024-12-13","current":-15.376556,"twenty":-35.741648,"median":-19.352594,"eighty":-13.764182,"marketCap":3551151967},{"date":"2024-12-20","current":-14.497713,"twenty":-35.546493,"median":-19.273329,"eighty":-13.764182,"marketCap":3329806452},{"date":"2024-12-27","current":-15.179905,"twenty":-35.418957,"median":-19.167386,"eighty":-13.764182,"marketCap":3483785941},{"date":"2025-01-03","current":-14.913703,"twenty":-35.25196,"median":-19.110348,"eighty":-13.764182,"marketCap":3426043632},{"date":"2025-01-10","current":-13.750925,"twenty":-34.933941,"median":-19.027831,"eighty":-13.754891,"marketCap":3146955808},{"date":"2025-01-17","current":-13.361676,"twenty":-34.446644,"median":-18.949286,"eighty":-13.704922,"marketCap":3060342346},{"date":"2025-01-24","current":-13.529011,"twenty":-34.269926,"median":-18.916804,"eighty":-13.694027,"marketCap":3118084654},{"date":"2025-01-28","current":-13.464721,"twenty":-34.170079,"median":-18.907538,"eighty":-13.67642,"marketCap":3118084654},{"date":"2025-02-07","current":-15.122505,"twenty":-33.185621,"median":-18.746316,"eighty":-13.668964,"marketCap":3483785941},{"date":"2025-02-14","current":-16.67621,"twenty":-32.529754,"median":-18.691754,"eighty":-13.668964,"marketCap":3839863509},{"date":"2025-02-21","current":-18.324448,"twenty":-31.716657,"median":-18.612372,"eighty":-13.668964,"marketCap":4234435950},{"date":"2025-02-28","current":-24.569098,"twenty":-30.791932,"median":-18.612372,"eighty":-13.668964,"marketCap":5658746225},{"date":"2025-03-07","current":-25.261571,"twenty":-30.029344,"median":-18.603349,"eighty":-13.668604,"marketCap":5841596868},{"date":"2025-03-14","current":-23.047481,"twenty":-28.794501,"median":-18.603349,"eighty":-13.668604,"marketCap":5331539810},{"date":"2025-03-21","current":-30.797536,"twenty":-28.744886,"median":-18.603349,"eighty":-13.668604,"marketCap":7121551371},{"date":"2025-03-28","current":44.165917,"twenty":-28.393605,"median":-18.522823,"eighty":-13.656111,"marketCap":7862577663},{"date":"2025-04-03","current":42.845017,"twenty":-28.217133,"median":-18.487302,"eighty":-13.645978,"marketCap":7612360993},{"date":"2025-04-11","current":34.734253,"twenty":-28.217133,"median":-18.487302,"eighty":-13.613827,"marketCap":6130308410},{"date":"2025-04-17","current":36.065457,"twenty":-28.158527,"median":-18.48348,"eighty":-13.574068,"marketCap":6380525080},{"date":"2025-04-25","current":37.556149,"twenty":-28.275738,"median":-18.491125,"eighty":-13.557411,"marketCap":6649989186},{"date":"2025-05-02","current":42.574598,"twenty":-28.217133,"median":-18.487302,"eighty":-13.526841,"marketCap":7554618684},{"date":"2025-05-09","current":39.514662,"twenty":-28.275738,"median":-18.491125,"eighty":-13.490846,"marketCap":7060873063},{"date":"2025-05-16","current":35.776948,"twenty":-28.275738,"median":-18.453232,"eighty":-13.440013,"marketCap":6445211106},{"date":"2025-05-23","current":47.38287,"twenty":-28.275738,"median":-18.402278,"eighty":-13.368618,"marketCap":8561549082},{"date":"2025-05-30","current":47.34521,"twenty":-28.275738,"median":-18.33304,"eighty":-13.277541,"marketCap":8592354976},{"date":"2025-06-06","current":42.147937,"twenty":-28.275738,"median":-18.299422,"eighty":-13.14218,"marketCap":7668652761},{"date":"2025-06-13","current":42.289865,"twenty":-28.275738,"median":-18.27405,"eighty":-13.070276,"marketCap":7697518456},{"date":"2025-06-20","current":35.964015,"twenty":-28.275738,"median":-18.27405,"eighty":-13.029979,"marketCap":6533268789},{"date":"2025-06-27","current":32.483216,"twenty":-28.217133,"median":-18.185823,"eighty":-12.946884,"marketCap":5917467313},{"date":"2025-07-04","current":34.066162,"twenty":-28.217133,"median":-18.046648,"eighty":-12.88485,"marketCap":6206124255},{"date":"2025-07-11","current":36.268142,"twenty":-28.217133,"median":-18.029621,"eighty":-12.840289,"marketCap":6600622076},{"date":"2025-07-18","current":45.76756,"twenty":-28.217133,"median":-18.029621,"eighty":-12.796764,"marketCap":8322941830},{"date":"2025-07-25","current":48.635945,"twenty":-28.217133,"median":-18.029621,"eighty":-12.69525,"marketCap":8876728670},{"date":"2025-08-01","current":50.491081,"twenty":-28.217133,"median":-18.029621,"eighty":-12.5376,"marketCap":9158375422},{"date":"2025-08-08","current":48.602584,"twenty":-28.217133,"median":-18.029621,"eighty":-12.398637,"marketCap":8837880842},{"date":"2025-08-15","current":48.140623,"twenty":-28.217133,"median":-18.029621,"eighty":-12.315906,"marketCap":8740761273},{"date":"2025-08-22","current":57.950472,"twenty":-28.217133,"median":-18.029621,"eighty":-12.254489,"marketCap":10488913527},{"date":"2025-08-29","current":49.451084,"twenty":-28.217133,"median":-18.029621,"eighty":-12.194762,"marketCap":8993272154},{"date":"2025-09-05","current":39.453945,"twenty":-28.217133,"median":-18.029621,"eighty":-12.124322,"marketCap":10032451550},{"date":"2025-09-12","current":47.42741,"twenty":-28.217133,"median":-18.029621,"eighty":-12.096265,"marketCap":12081674470},{"date":"2025-09-19","current":44.828603,"twenty":-28.217133,"median":-18.029621,"eighty":-12.019811,"marketCap":11411549439},{"date":"2025-09-26","current":46.934282,"twenty":-28.217133,"median":-18.029621,"eighty":-11.831972,"marketCap":11916571202},{"date":"2025-10-03","current":58.385068,"twenty":-28.158527,"median":-18.021599,"eighty":-11.755883,"marketCap":14859294164},{"date":"2025-10-10","current":49.909916,"twenty":-28.217133,"median":-18.029621,"eighty":-11.664242,"marketCap":12683815802},{"date":"2025-10-17","current":55.035469,"twenty":-28.217133,"median":-18.029621,"eighty":-11.470781,"marketCap":13975506079},{"date":"2025-10-24","current":45.261337,"twenty":-28.217133,"median":-18.029621,"eighty":-11.338351,"marketCap":11497678332},{"date":"2025-10-31","current":43.864804,"twenty":-28.217133,"median":-18.029621,"eighty":-11.156758,"marketCap":11159539015},{"date":"2025-11-07","current":36.144291,"twenty":-28.217133,"median":-18.029621,"eighty":-11.054596,"marketCap":9189637780},{"date":"2025-11-14","current":37.226268,"twenty":-28.217133,"median":-18.029621,"eighty":-10.962516,"marketCap":9491548883},{"date":"2025-11-21","current":37.509917,"twenty":-28.217133,"median":-18.029621,"eighty":-10.62574,"marketCap":9559414912},{"date":"2025-11-28","current":40.619308,"twenty":-28.217133,"median":-18.029621,"eighty":-10.506267,"marketCap":10389445551},{"date":"2025-12-05","current":41.722201,"twenty":-28.217133,"median":-18.029621,"eighty":-10.418991,"marketCap":10689886607},{"date":"2025-12-12","current":40.470968,"twenty":-28.217133,"median":-18.029621,"eighty":-10.328476,"marketCap":10388480751},{"date":"2025-12-19","current":41.091429,"twenty":-28.217133,"median":-18.029621,"eighty":-10.278072,"marketCap":10572604944},{"date":"2025-12-24","current":39.124027,"twenty":-28.217133,"median":-18.029621,"eighty":-10.261216,"marketCap":10097758342},{"date":"2026-01-02","current":35.829064,"twenty":-28.275738,"median":-18.037644,"eighty":-10.131708,"marketCap":9283735597},{"date":"2026-01-09","current":40.755473,"twenty":-28.275738,"median":-18.037644,"eighty":-10.049921,"marketCap":10586521438},{"date":"2026-01-16","current":37.910275,"twenty":-28.275738,"median":-18.037644,"eighty":-9.985778,"marketCap":9879461909},{"date":"2026-01-23","current":35.826131,"twenty":-28.275738,"median":-18.037644,"eighty":-9.870301,"marketCap":9327374332},{"date":"2026-01-30","current":32.996697,"twenty":-28.275738,"median":-18.037644,"eighty":-9.785633,"marketCap":8630000550},{"date":"2026-02-06","current":32.433,"twenty":-28.275738,"median":-18.037644,"eighty":-9.718873,"marketCap":8504085839},{"date":"2026-02-13","current":32.945618,"twenty":-28.217133,"median":-18.029621,"eighty":-9.613637,"marketCap":8688115032},{"date":"2026-02-20","current":33.839118,"twenty":-28.334344,"median":-18.046648,"eighty":-9.565339,"marketCap":8910887212},{"date":"2026-02-27","current":31.68928,"twenty":-28.334344,"median":-18.046648,"eighty":-9.509688,"marketCap":8436285610},{"date":"2026-03-06","current":28.792488,"twenty":-28.334344,"median":-18.046648,"eighty":-9.385032,"marketCap":7603311371},{"date":"2026-03-13","current":31.398747,"twenty":-28.334344,"median":-18.046648,"eighty":-9.277488,"marketCap":8329742394},{"date":"2026-03-20","current":30.601868,"twenty":-28.334344,"median":-18.046648,"eighty":-9.050312,"marketCap":8087598719},{"date":"2026-03-27","current":-57.808719,"twenty":-28.394262,"median":-17.932602,"eighty":20.857646,"marketCap":7458025166},{"date":"2026-04-02","current":-67.544334,"twenty":-28.812518,"median":-17.932602,"eighty":20.857646,"marketCap":8755915260},{"date":"2026-04-10","current":-69.622458,"twenty":-29.302533,"median":-17.932602,"eighty":20.857646,"marketCap":9094916404},{"date":"2026-04-17","current":-88.195901,"twenty":-30.2986,"median":-17.932602,"eighty":20.857646,"marketCap":11526038894},{"date":"2026-04-24","current":-83.151421,"twenty":-30.665238,"median":-17.932602,"eighty":20.857646,"marketCap":10867408100},{"date":"2026-04-30","current":-76.285681,"twenty":-30.923663,"median":-17.932602,"eighty":20.857646,"marketCap":9976319379},{"date":"2026-05-08","current":-74.05623,"twenty":-31.791607,"median":-17.909322,"eighty":28.135623,"marketCap":9714804210},{"date":"2026-05-15","current":-65.687804,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":8639686297},{"date":"2026-05-22","current":-69.01209,"twenty":-32.586236,"median":-17.932602,"eighty":20.857646,"marketCap":9056173416},{"date":"2026-05-29","current":-66.934096,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":8814029742},{"date":"2026-06-05","current":-51.045913,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":6731594144},{"date":"2026-06-12","current":-52.182919,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":6876880348},{"date":"2026-06-18","current":-53.671086,"twenty":-32.586236,"median":-17.932602,"eighty":20.857646,"marketCap":7089966782},{"date":"2026-06-26","current":-49.660978,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":6528193457},{"date":"2026-07-03","current":-56.17656,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":7390224938},{"date":"2026-07-10","current":-56.462771,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":7418761299},{"date":"2026-07-17","current":-51.047611,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":6731121544},{"date":"2026-07-24","current":-58.452905,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":7709313308},{"date":"2026-07-31","current":-54.750665,"twenty":-32.226362,"median":-17.873419,"eighty":28.196225,"marketCap":7234745026},{"date":"2026-08-07","current":-58.667923,"twenty":-32.226362,"median":-17.873419,"eighty":28.196225,"marketCap":7767423709},{"date":"2026-08-10","current":-62.063269,"twenty":-32.226362,"median":-17.873419,"eighty":28.196225,"marketCap":8222621857}],"updateTime":1786481205265},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09966\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657084510","title":"Alphamab Oncology Licenses Cancer Drug Candidate to Pathos AI for Up to $2.09 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2657084510","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657084510?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:04","pubTimestamp":1785924260,"startTime":"0","endTime":"0","summary":"Alphamab Oncology's  wholly owned subsidiary, Jiangsu Alphamab Biopharmaceuticals, has granted Pathos AI an exclusive license to develop and commercialize cancer drug JSKN016 outside mainland China, Hong Kong, Macau and Taiwan, in a deal worth up to $2.09 billion.Under the agreement, Alphamab will receive a $125 million upfront payment and is eligible for additional milestone payments and tiered royalties based on sales in the licensed markets, according to a Hong Kong bourse filing.As part of the deal, Pathos AI granted Alphamab an option to invest up to $62.5 million in its preferred shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGIX","CHAT","ARTY","BK1161","09966","AIPO","BK1574","QTOC","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135953507","title":"Alphamab Oncology (ALPHAMAB-B) Reports Stable Share Capital and Option Movements for July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1135953507","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135953507?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:29","pubTimestamp":1785922177,"startTime":"0","endTime":"0","summary":"Alphamab Oncology filed its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026. The filing shows no changes in either authorised or issued share capital...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656558078","title":"CSPC Pharma Unit, Alphamab Oncology's Breast Cancer Drug Application Granted Priority Review in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2656558078","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656558078?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:34","pubTimestamp":1785843297,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical  said a new drug application for Anbenitamab was accepted by China's National Medical Products Administration, according to a Tuesday Hong Kong bourse filing.The application for Anbenitamab, co-developed by Shanghai JMT-Bio Technology, a unit of the company, and Alphamab Oncology , has also been included in the priority review and approval procedures.The indication for the application is Anbenitamab in combination with docetaxel  ± carboplatin as neoadjuvant therapy to treat breast cancer in adults.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","IE00B031HY20.USD","LU1226287529.USD","LU1951186391.HKD","LU0072913022.USD","IE00BZ08YT58.USD","HK0000165453.HKD","LU0067412154.USD","IE00BZ08YS42.EUR","LU1226287875.USD","LU0501845795.SGD","IE00B5MMRT66.SGD","LU0326950275.SGD","BK1161","LU1008478684.HKD","IE00B543WZ88.USD","LU1813983027.USD","SG9999004220.SGD","BK1521","LU1993786604.SGD","LU0315179316.USD","LU0140636845.USD","LU1328277881.USD","LU1960683339.HKD","LU1152091168.USD","BK1515","LU0314109678.HKD","KURE","LU1226287792.SGD","BK1191","LU0880133367.SGD","LU1807302812.USD","LU1226288253.USD","LU2039709279.SGD","IE0008369823.USD","LU1226288170.HKD","09966","IE0008368742.USD","LU1152091754.HKD","01093","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116442889","title":"ALPHAMAB-B's Novel Drug Application for Anniutuo (KN026) in HER2-Positive Breast Cancer Neoadjuvant Therapy Accepted by Chinese Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1116442889","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116442889?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:11","pubTimestamp":1785838261,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966.HK) announced that the New Drug Application (NDA) for Anniutuo (brand name: Ennituo®, development code: KN026), developed in collaboration with CSPC Pharmaceutical Group (01093.HK)...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09966","BK1574","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100652556","title":"Alphamab Oncology receives NMPA priority review for Anbenitamab NDA in neoadjuvant HER2+ breast-cancer therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1100652556","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100652556?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:06","pubTimestamp":1785837961,"startTime":"0","endTime":"0","summary":"Alphamab Oncology announced that China’s National Medical Products Administration (NMPA) has accepted, and granted priority review status to, the new drug application (NDA) for Anbenitamab (trade...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656153495","title":"Alphamab Oncology Says NMPA Accepts NDA for Anbenitamab (kn026)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656153495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656153495?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:04","pubTimestamp":1785837881,"startTime":"0","endTime":"0","summary":"BRIEF-Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)Aug 4 (Reuters)-Alphamab Oncology9966.HK:NMPA ACCEPTS NDA FOR ANBENITAMAB (KN026) AS NEOADJUVANT HER2+ BREAST CANCER TREATMENTFurther company coverage:9966.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN44107H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1008478684.HKD","KURE","LU2039709279.SGD","LU0315179316.USD","LU0140636845.USD","IE00BZ08YR35.GBP","IE0008369823.USD","LU1951186391.HKD","LU1226287875.USD","LU1226287792.SGD","LU1960683339.HKD","IE0008368742.USD","HK0000165453.HKD","LU0880133367.SGD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU1993786604.SGD","BK1521","LU1226287529.USD","LU1226288170.HKD","LU0501845795.SGD","LU1226288253.USD","LU1152091754.HKD","BK1191","IE00BZ08YT58.USD","09966","LU1152091168.USD","LU0067412154.USD","LU0326950275.SGD","BK1574","LU0314109678.HKD","LU1813983027.USD","01093","SG9999004220.SGD","BK1515","LU1328277881.USD","IE00B543WZ88.USD","LU1807302812.USD","BK1161","LU0072913022.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656343715","title":"Alphamab Oncology - Nmpa Accepts Nda for Anbenitamab (Kn026) as Neoadjuvant Her2+ Breast Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2656343715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656343715?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:01","pubTimestamp":1785837662,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN44107H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656754582","title":"HK-Listed Alphamab Hits 2-Month High on Breast Cancer Drug Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2656754582","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656754582?lang=en_us&edition=fundamental","pubTime":"2026-08-04 13:58","pubTimestamp":1785823091,"startTime":"0","endTime":"0","summary":"BUZZ-HK-listed Alphamab hits 2-month high on breast cancer drug licensing deal** Shares of Alphamab Oncology9966.HKjump as much as 12.8% to HK$8.35, their highest point since June 2** Stock last up 5.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL1N44104T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09966","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145569255","title":"ALPHAMAB-B Surges Over 12% in Morning Trade Following $2.1 Billion TROP2/HER3 Dual Antibody ADC Export Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1145569255","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145569255?lang=en_us&edition=fundamental","pubTime":"2026-08-04 10:02","pubTimestamp":1785808931,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) saw its stock price surge more than 12% during early trading hours, reaching a high of 8.32 Hong Kong dollars with a trading volume of 7.62 million Hong Kong dollars. As of the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","NETL","BK1574","09966","BK4231","ADC","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588482","title":"Alphamab Oncology - Jiangsu Alphamab to Receive $125 Mln Upfront, up to $2.09 Bln Total from Pathos AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588482?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:00","pubTimestamp":1785801650,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4401MK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588417","title":"Alphamab Oncology - Unit Granted Pathos AI Exclusive License to Commercialize Jskn016 in Territories Outside Chinese Mainland, HK, Macau, Taiwan","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588417","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588417?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:00","pubTimestamp":1785801650,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4401MK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","09966","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588104","title":"Alphamab Oncology Licenses Jskn016 Ex-China Rights to Pathos AI for up to USD 2.09 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588104","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588104?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:00","pubTimestamp":1785801649,"startTime":"0","endTime":"0","summary":"Alphamab Oncology licenses JSKN016 ex-China rights to Pathos AI for up to USD 2.09 billionAlphamab Oncology licensed JSKN016 to Pathos AI on Aug. 3, 2026 for development, manufacturing, commercializat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL3tV1k3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656106588","title":"Pathos AI Enters Global Licensing Agreement with Alphamab Oncology on Jskn016, a First-in-Class Trop2/Her3 Bispecific ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2656106588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656106588?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:00","pubTimestamp":1785801600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA4YWTHK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656303034","title":"Alphamab Oncology Announces Approval from CDE for Jskn033 to Initiate a Phase III Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2656303034","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656303034?lang=en_us&edition=fundamental","pubTime":"2026-08-04 01:23","pubTimestamp":1785777808,"startTime":"0","endTime":"0","summary":"BRIEF-Alphamab Oncology Announces Approval From CDE For JSKN033 To Initiate A Phase III Clinical StudyAug 3 (Reuters)-Alphamab Oncology9966.HK:APPROVAL FROM CDE FOR JSKN033 TO INITIATE A PHASE III CLINICAL STUDY FOR TREATMENT OF CERVICAL CANCERFurther company coverage:9966.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN4400TA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197142192","title":"ALPHAMAB-B wins CDE green light to start Phase III trial of subcutaneous bispecific ADC/PD-L1 combo JSKN033 for hard-to-treat cervical cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1197142192","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197142192?lang=en_us&edition=fundamental","pubTime":"2026-08-03 22:26","pubTimestamp":1785767199,"startTime":"0","endTime":"0","summary":"Alphamab-B (Alphamab Oncology) disclosed that China’s Center for Drug Evaluation under the National Medical Products Administration has approved the launch of a Phase III study (JSKN033-301)...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656096374","title":"Alphamab Oncology - Approval from Cde for Jskn033 to Initiate a Phase Iii Clinical Study for Treatment of Cervical Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2656096374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656096374?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:46","pubTimestamp":1785764793,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN4400TA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656740563","title":"Alphamab Oncology Says China CDE Clears Jskn033 Phase 3 Trial in Recurrent or Metastatic Cervical Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2656740563","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656740563?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:45","pubTimestamp":1785764742,"startTime":"0","endTime":"0","summary":"Alphamab Oncology says China CDE clears JSKN033 Phase 3 trial in recurrent or metastatic cervical cancerAlphamab Oncology secured China CDE clearance to start a Phase III trial of JSKN033 in recurrent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL9V9qcc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174087199","title":"Alphamab-B Shares Surge 10% on Breakthrough Therapy Designation for Breast Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1174087199","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174087199?lang=en_us&edition=fundamental","pubTime":"2026-07-15 11:04","pubTimestamp":1784084665,"startTime":"0","endTime":"0","summary":"Shares of Alphamab-B (09966) have surged more than 10%, climbing 10.43% to HK$8.15 by the time of writing, with a trading turnover of HK$5.97 million.The rally follows news that the company's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","VXUS","BK1161","BK1574","BK4585","09966","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651177425","title":"Alphamab Oncology Says China Regulator Grants Breakthrough Tag for Anbenitamab in First-line HER2+ Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2651177425","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651177425?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:02","pubTimestamp":1784026927,"startTime":"0","endTime":"0","summary":"Alphamab Oncology says China regulator grants breakthrough tag for anbenitamab in first-line HER2+ advanced breast cancerAlphamab Oncology’s anti-HER2 bispecific antibody anbenitamab (KN026) won NMPA ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL6rtl11:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651177134","title":"Alphamab Oncology - Anbenitamab (kn026) Granted Breakthrough Therapy Designation by Nmpa for Her2+ Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2651177134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651177134?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:00","pubTimestamp":1784026825,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G0FM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":125,"code":"91000000","status":"200"}]}}